Multivalent forms of the Notch ligand DLL-1 enhance antitumor T cell immunity in lung cancer and improve efficacy of EGFR targeted therapy

Activation of Notch signaling in hematopoietic cells by tumors contributes to immune escape. T cell defects in tumors can be reversed by treating tumor-bearing mice with multivalent forms of the Notch receptor ligand DLL-1, but the immunologic correlates of this effect have not been elucidated. Here...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Biktasova, Asel K., Dudimah, Duafalia F., Uzhachenko, Roman V., Park, Kyungho, Akhter, Anwari, Arasada, Rajeswara R., Evans, Jason V., Novitskiy, Sergey V., Tchekneva, Elena E., Carbone, David P., Shanker, Anil, Dikov, Mikhail M
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4651735/
https://ncbi.nlm.nih.gov/pubmed/26404003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-1154
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki